人心肌蛋白质组学揭示肥厚型心肌病信号通路失调
该多中心病例对照研究对99例肥厚型心肌病(HCM)患者和15例非衰竭心脏对照者的心肌样本进行SomaScan检测,分析7,289种蛋白质,发现Ras-MAPK、泛素介导的蛋白水解、血管生成相关及Hippo等通路失调,转录组学验证支持上述发现。
要点
- HCM心肌蛋白质组学揭示Ras-MAPK、泛素介导蛋白水解、血管生成及Hippo通路失调。
- 代谢、炎症和细胞外基质等已知通路亦存在失调。
- 与严重HCM临床指标相关的蛋白通路分析及转录组学验证支持上述发现。
核心结论
- HCM心肌存在新识别(如Ras-MAPK)和已知通路的失调,与发病及进展为严重形式相关。
研究设计与样本
- 多中心病例对照研究,纳入99例HCM患者和15例非衰竭心脏对照者,采集心肌样本。
- 使用SomaScan检测7,289种蛋白质,并进行转录组学验证。
主要发现
- 差异表达蛋白通路分析显示Ras-MAPK、泛素介导的蛋白水解、血管生成相关(如HIF-1、VEGF)及Hippo通路失调。
- 代谢、炎症和细胞外基质等已知HCM相关通路亦失调。
- 与严重HCM临床指标(如LVEF降低、房颤、室性心动过速)相关的蛋白通路分析及差异表达基因分析支持上述发现。
关键数值与推荐
- 通路分析采用错误发现率<0.05。
临床怎么用
- 研究结果提示Ras-MAPK等通路可能成为HCM发病和进展的潜在干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiac disease. Signaling pathways that link genetic sequence variants to clinically overt HCM and progression to severe forms of HCM remain unknown. OBJECTIVES: The purpose of this study was to identify signaling pathways that are differentially regulated in HCM, using proteomic profiling of human myocardium, confirmed with transcriptomic profiling. METHODS: In this multicenter case-control study, myocardial samples were obtained from cases with HCM and control subjects with nonfailing hearts. Proteomic profiling of 7,289 proteins from myocardial samples was performed using the SomaScan assay (SomaLogic). Pathway analysis of differentially expressed proteins was performed, using a false discovery rate <0.05. Pathway analysis of proteins whose concentrations correlated with clinical indicators of severe HCM (eg, reduced left ventricular ejection fraction, atrial fibrillation, and ventricular tachyarrhythmias) was also executed. Confirmatory analysis of differentially expressed genes was performed using myocardial transcriptomic profiling. RESULTS: The study included 99 HCM cases and 15 control subjects. Pathway analysis of differentially expressed proteins revealed dysregulation of the Ras-mitogen-activated protein kinase, ubiquitin-mediated proteolysis, angiogenesis-related (eg, hypoxia-inducible factor-1, vascular endothelial growth factor), and Hippo pathways. Pathways known to be dysregulated in HCM, including metabolic, inflammatory, and extracellular matrix pathways, were also dysregulated. Pathway analysis of proteins associated with clinical indicators of severe HCM and of differentially expressed genes supported these findings. CONCLUSIONS: The present study represents the most comprehensive (>7,000 proteins) and largest-scale (n = 99 HCM cases) proteomic profiling of human HCM myocardium to date. Proteomic profiling and confirmatory transcriptomic profiling elucidate dysregulation of both newly recognized (eg, Ras-mitogen-activated protein kinase) and known pathways associated with pathogenesis and progression to severe forms of HCM.
引用
- Lumish HS, Sherrid MV, Janssen PML, et al. Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2024. PMID: 39365226. doi:10.1016/j.jacc.2024.07.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。